major
task
respiratori
tract
exchang
inhal
atmospher
oxygen
carbon
dioxid
carri
bloodstream
ensur
thin
larg
surfac
area
form
type
type
ii
alveolar
epitheli
cell
upper
lower
respiratori
epithelia
line
thin
aqueou
layer
refer
airway
surfac
liquid
asl
alveolar
line
fluid
afl
respect
fluidic
compon
concert
action
surfact
mucu
ciliari
reduc
alveolar
surfac
tension
prevent
atelectasi
well
defend
invad
pathogen
maintain
composit
asl
afl
prevent
alveolar
flood
lung
fluid
homeostasi
tightli
control
express
activ
ion
channel
pump
channel
pump
establish
osmot
gradient
airspac
interstitium
drive
paracellular
aquaporin
mediat
fluid
movement
across
respiratori
epithelium
among
apic
amiloridesensit
epitheli
sodium
channel
enac
amilorideinsensit
cyclic
nucleotideg
cation
channel
cng
act
togeth
basolater
locat
na
katpas
nka
promot
transcellular
sodium
transport
accompani
alveolar
epithelium
chlorid
uptak
apic
cystic
fibrosi
membran
conduct
regul
cftr
howev
airway
cftr
promot
chlorid
secret
regul
mucu
densiti
addit
ion
channel
cacc
promot
apic
chlorid
secret
support
basolater
chlorid
uptak
via
cotransport
nkcc
well
potassium
ion
channel
contribut
cellular
membran
potenti
buildup
electrochem
gradient
necessari
apic
chlorid
secret
addit
factor
influenc
fluid
homeostasi
epitheli
im
permeabl
establish
tight
junction
protein
well
endotheli
integr
limit
extravas
fluid
blood
vessel
driven
chang
capillari
hydrostat
pressur
pulmonari
infect
commonli
disturb
ion
thu
fluid
homeostasi
result
abnorm
chang
asl
afl
alveolar
edema
format
viral
bacteri
pathogen
common
caus
agent
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
character
widespread
inflamm
within
lung
extens
flood
alveolar
airspac
proteinrich
exud
fluid
impair
ga
exchang
lead
respiratori
failur
result
mortal
rate
addit
sepsi
result
primari
infect
site
often
complic
develop
sever
lung
injuri
onset
bacteremia
result
lung
failur
account
mani
half
case
ard
although
pathogenderiv
effect
ion
transport
lung
injuri
report
caus
directli
cell
interact
accumul
evid
suggest
auto
paracrin
mediat
local
andor
system
inflammatori
respons
mount
upon
pathogen
recognit
replic
pathophysiolog
ion
transport
alveolar
fluid
clearanc
afc
result
edema
format
persist
importantli
mortal
ard
patient
repeatedli
found
correl
persist
alveolar
edema
review
highlight
advanc
understand
inflammatori
respons
pulmonari
infect
affect
ion
transport
includ
common
pattern
uniqu
pathway
activ
differ
respiratori
pathogen
mechan
might
modul
improv
outcom
ard
patient
cell
detect
pathogen
specif
special
pattern
recognit
receptor
produc
interferon
ifn
activ
suppress
given
pulmonari
infect
scenario
effect
ifn
fluid
homeostasi
seem
mostli
limit
gamma
ifn
attribut
modulatori
role
innat
adapt
immun
report
decreas
sodium
transport
level
low
uml
moreov
also
directli
decreas
chlorid
current
along
bronchial
epithelium
downregul
cftr
due
posttranscript
modul
cftr
messeng
rna
mrna
stabil
thu
halflif
contrast
class
ifn
usual
implic
mount
direct
cellular
pathogenrestrict
respons
modul
cftr
mrna
protein
abund
appear
neg
impact
nka
cell
membran
protein
abund
iav
infect
via
activ
metabol
sensor
ampkinas
ampk
howev
date
data
support
whether
effect
ion
transport
gener
respons
pulmonari
infect
tumor
necrosi
factor
alpha
classic
cytokin
produc
upon
local
system
inflamm
regul
differenti
process
prolifer
differenti
immun
cell
well
cell
death
initi
conflict
studi
becom
clear
play
dichotom
role
lung
fluid
reabsorpt
one
hand
ligat
receptor
tnf
receptor
also
name
inhibit
enac
activ
vitro
vivo
via
pkcdepend
mechan
hand
distinct
lectinlik
domain
tnf
differ
receptorbind
domain
mimick
acid
circular
tip
peptid
report
increas
edema
reabsorpt
rat
bacteri
pneumonia
applic
tip
peptid
demonstr
elev
enac
express
open
probabl
result
enhanc
afc
p
aeruginosatr
rat
vivo
furthermor
report
increas
nka
activ
addit
direct
effect
ion
channel
pump
alveolar
epithelium
interact
also
modul
integr
alveolar
barrier
increas
endotheli
express
chemoattract
adhes
molecul
includ
formerli
call
neutrophil
chemotact
factor
axi
intercellular
adhes
platelet
endotheli
cell
adhes
vascular
adhes
thu
promot
excess
recruit
mononuclear
phagocyt
neutrophil
lung
inflamm
importantli
besid
cellular
transmigr
neutrophilderiv
proteas
neutrophil
extracellular
trap
central
driver
endotheli
epitheli
injuri
beta
one
commonli
found
cytokin
pulmonari
edema
bronchoalveolar
lavag
fluid
experiment
human
ard
exampl
induc
klebsiella
pneumonia
bacteri
pneumonia
mainli
produc
macrophag
similarli
major
impact
cell
prolifer
differenti
cell
death
pulmonari
inflamm
increas
lung
barrier
permeabl
vitro
vivo
model
ard
may
contribut
alveolar
edema
lung
injuri
model
impair
fluid
reabsorpt
lung
part
attribut
decreas
sodium
absorpt
due
decreas
express
traffick
apic
membran
atii
cell
addit
streptococcu
pneumonia
infect
also
influenc
ion
transport
process
via
activ
procoagul
factor
thrombin
particular
demonstr
impair
afc
increas
endocytosi
alveolar
nka
chemotact
factor
correl
neutrophil
accumul
distal
airspac
patient
ard
predictor
mortal
secret
bronchial
epitheli
cell
induc
mycoplasma
pneumonia
antigen
live
pneumonia
well
sever
acut
respiratori
syndrom
coronaviru
spike
protein
respiratori
syncyti
viru
infect
rate
afc
impair
high
level
significantli
lower
patient
pulmonari
edema
fluid
concentr
pgml
mechanist
inhibit
adrenerg
receptor
agoniststimul
fluid
transport
across
rat
human
alveolar
epithelia
inhibit
mediat
desensit
downregul
cell
membran
associ
inhibit
cyclic
amp
gener
normal
observ
respons
agonist
stimul
cytokin
critic
factor
develop
ard
besid
establish
role
dampen
inflammatori
respons
eg
drive
macrophag
toward
antiinflammatori
phenotyp
increas
alveolar
epitheli
permeabl
promot
edema
format
upon
lipopolysaccharid
lp
stimul
furthermor
shown
inhibit
amiloridesensit
sodium
transport
inhibit
subunit
promot
activ
decreas
mrna
protein
express
addit
peter
et
al
demonstr
lead
subsequ
activ
phospholipas
nadph
oxidas
activ
result
product
reactiv
oxygen
speci
ro
turn
reduc
cell
surfac
stabil
complex
thu
promot
edema
fluid
accumul
moreov
decreas
nka
subunit
express
result
decreas
nka
activ
lung
epitheli
cell
support
role
lung
injuri
level
increas
lung
fluid
patient
aliard
murin
model
streptococcu
pneumonia
iav
infect
note
propos
aggrav
edema
format
iav
infect
increas
epitheli
cell
death
caus
disrupt
epitheli
barrier
integr
moreov
implic
upregul
cellular
adhesin
increas
host
suscept
bacteri
coinfect
pose
major
risk
increas
viral
pneumoniaassoci
morbid
mortal
influenza
epidem
princip
role
trail
highli
releas
lung
macrophag
upon
viral
infect
drive
infect
cell
apoptosi
limit
pathogen
spread
trail
report
produc
especi
viral
respiratori
infect
includ
iav
adenoviru
paramyxoviru
infect
cell
sensit
trailinduc
apoptosi
enhanc
infect
cell
increas
trailreceptor
express
howev
process
also
affect
alveolar
epitheli
barrier
integr
lead
edema
accumul
moreov
trail
signal
lead
nka
downregul
iav
infect
noninfect
neighbor
alveolar
epitheli
cell
mediat
ampk
accordingli
trail
signal
reduc
afc
promot
edema
format
addit
trail
releas
upon
iav
infect
favor
bacteri
superinfect
pneumonia
aggrav
lung
injuri
acut
infect
extracellular
nucleotid
often
serv
danger
signal
involv
recognit
control
pathogen
promot
recruit
inflammatori
cell
stimul
proinflammatori
cytokin
increas
product
ro
nitric
oxid
extracellular
atp
releas
airway
epithelia
produc
endotheli
cell
upon
acut
inflamm
bind
purinerg
receptor
promot
calcium
signalingdepend
stimul
cacc
decreas
open
probabl
enac
moreov
extracellular
adenosin
produc
atp
hydrolysi
via
increas
bronchoalveolar
lavag
fluid
iavinfect
mice
genet
delet
protect
howev
limit
extent
involv
progress
lung
injuri
effect
pulmonari
edema
format
reactiv
oxygen
nitrogen
speci
shown
involv
develop
epitheli
injuri
patholog
situat
includ
lpssepsisinduc
lung
injuri
well
viral
pneumonia
ron
produc
larg
quantiti
alveolar
phagocyt
studi
rabbit
piglet
lung
elucid
ron
affect
afc
edema
persist
inhibit
activ
enac
alveolar
epitheli
nka
add
complex
airway
alveolar
fluid
regul
suggest
ion
channel
pump
transport
modul
signal
factor
releas
upon
pulmonari
infect
also
chang
ion
transport
influenc
respiratori
inflammatori
respons
exampl
transport
play
critic
role
basolater
ion
affect
sever
pneumonia
sepsi
consequ
sever
lung
injuri
regul
abil
barrier
modul
neutrophil
infiltr
air
space
lung
lack
mous
model
pneumonia
infect
k
pneumonia
lp
result
increas
number
neutrophil
lavag
fluid
decreas
bacteremia
importantli
mortal
therefor
suggest
activ
contribut
edema
format
decreas
neutrophil
migrat
lung
air
space
probabl
contribut
reduc
bacteri
kill
subsequ
develop
sever
sepsi
similarli
mutat
cftr
amplifi
lung
inflamm
upregul
proinflammatori
respons
caus
increas
cytokin
product
upon
activ
lung
epitheli
cell
lack
function
neutrophil
cftr
model
lpsinduc
lung
inflamm
contribut
inflammatori
imbal
transloc
reduct
antiinflammatori
cytokin
favor
increas
lung
vascular
permeabl
also
ion
imbal
respons
express
viral
ion
channel
viroporin
recogn
potenti
pathogen
recognit
pathway
favor
inflammasom
activ
releas
tnf
might
contribut
limit
viru
spread
state
pulmonari
sever
lead
lung
edema
accumul
impair
edema
clearanc
lung
edema
result
impair
oxygen
organ
dysfunct
resolv
lead
high
mortal
patient
ard
current
treatment
option
infectioninduc
ard
includ
antivir
antibiot
howev
increas
antibiot
pathogen
k
pneumonia
escherichia
coli
staphylococcu
aureu
p
aeruginosa
lack
readili
avail
treatment
option
acut
emerg
agent
zoonot
influenza
virus
middl
east
respiratori
syndrom
coronaviru
current
approach
treat
ard
patient
includ
low
tidal
volum
mechan
ventil
posit
end
expiratori
pressur
fluid
manag
extracorpor
membran
oxygen
measur
primarili
improv
oxygen
interestingli
lungprotect
ventil
strategi
report
reduc
mortal
patient
ard
also
diminish
number
neutrophil
concentr
proinflammatori
cytokin
releas
patient
lavag
fluid
novel
approach
target
host
mediat
known
promot
lung
edema
format
impair
clearanc
studi
tip
peptid
see
tumor
necrosi
factor
alpha
administr
ard
studi
initi
report
show
synthet
peptid
mimick
tip
induc
enac
activ
type
ii
alveolar
epitheli
cell
dog
pig
rat
improv
lung
function
porcin
lung
injuri
model
subsequ
phase
ii
clinic
trial
ventil
ard
patient
result
improv
afc
oxygen
patient
also
mesenchym
stem
cell
report
improv
epitheli
barrier
integr
human
aec
ii
treat
cytokin
mix
compos
combin
current
test
safeti
efficaci
phase
ii
trial
clinic
trial
identifi
studi
previous
shown
improv
vectori
sodium
transport
edema
clearanc
improv
ard
outcom
possibl
due
enhanc
inflammatori
respons
driven
lung
macrophag
treatment
option
target
para
autocrin
signal
event
affect
afc
preclin
model
includ
glucocorticoid
suppress
inflamm
upregul
nka
enac
neutral
antibodi
direct
virusspecif
releas
macrophag
trail
improv
nka
express
well
afc
iavinfect
mice
nitric
oxid
synthas
inhibitor
aminoguanidin
n
omega
monomethyllarginin
lnmma
protect
pulmonari
edema
lpsinduc
lung
injuri
well
iav
infect
pathogeninduc
lung
injuri
also
sepsi
lead
widespread
respiratori
inflamm
favor
accumul
lung
edema
lead
multiorgan
dysfunct
poor
outcom
recent
advanc
develop
novel
treatment
strategi
target
respiratori
ion
homeostasi
show
encourag
result
identifi
promis
candid
improv
afc
ali
could
potenti
improv
surviv
patient
ard
cp
sh
js
el
perform
bibliograph
research
draft
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
